Language Select
Varian Logo

INVESTOR RELATIONS

 

Varian Updates Investors on Proposed Reimbursement Changes

Thursday, August 8, 2019

Presentation

Third Quarter FY2019 Earnings Results Conference Call

Wednesday, July 24, 2019
1:30pm PDT

Listen to Webcast
Presentation
 

Varian Expands Cancer Care Solutions Portfolio with Interventional Oncology Acquisitions

Tuesday, June 11, 2019
6:45am PST

Listen to Webcast
Presentation
To Access the Call:
877-407-9708 / 201-689-8259

Recent News
Aug 21, 2019

Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to...

Aug 21, 2019

Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating...

Aug 19, 2019

Varian (NYSE: VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York,...

More news >


Thursday, August 8, 2019

Presentation
 

Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5631
E-mail: investors@varian.com
IR Contacts

NYSE: VAR
NYSEVAR
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo